These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21452041)

  • 1. The expression and significance of pThr32-FOXO3a in human ovarian cancer.
    Lu M; Xiang J; Xu F; Wang Y; Yin Y; Chen D
    Med Oncol; 2012 Jun; 29(2):1258-64. PubMed ID: 21452041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of Foxo3a is associated with poor prognosis in ovarian cancer patients.
    Fei M; Zhao Y; Wang Y; Lu M; Cheng C; Huang X; Zhang D; Lu J; He S; Shen A
    Cancer Invest; 2009 Jan; 27(1):52-9. PubMed ID: 19160093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and prognosis of FOXO3a and Skp2 in human ovarian cancer.
    Lu M; Zhao Y; Xu F; Wang Y; Xiang J; Chen D
    Med Oncol; 2012 Dec; 29(5):3409-15. PubMed ID: 22714061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma.
    Lu M; Ma J; Xue W; Cheng C; Wang Y; Zhao Y; Ke Q; Liu H; Liu Y; Li P; Cui X; He S; Shen A
    Pathol Oncol Res; 2009 Dec; 15(4):679-87. PubMed ID: 19404778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
    Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
    Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic implications of FOXO3a and Ki67 in lung adenocarcinomas.
    Liu HB; Gao XX; Zhang Q; Liu J; Cui Y; Zhu Y; Liu YF
    Asian Pac J Cancer Prev; 2015; 16(4):1443-8. PubMed ID: 25743813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma.
    Zhang J; Wang JC; Li YH; Wang RX; Fan XM
    Chin Med J (Engl); 2017 Feb; 130(3):280-287. PubMed ID: 28139510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognosis of FOXO3a and HIF-1α in nasopharyngeal carcinoma.
    Shou Z; Lin L; Liang J; Li JL; Chen HY
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):585-93. PubMed ID: 22209974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7.
    Lu Z; Yang H; Sutton MN; Yang M; Clarke CH; Liao WS; Bast RC
    Cell Death Differ; 2014 Aug; 21(8):1275-89. PubMed ID: 24769729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of the FOXO3a gene is associated with poor prognosis in primary gastric adenocarcinoma patients.
    Yang XB; Zhao JJ; Huang CY; Wang QJ; Pan K; Wang DD; Pan QZ; Jiang SS; Lv L; Gao X; Chen HW; Yao JY; Zhi M; Xia JC
    PLoS One; 2013; 8(10):e78158. PubMed ID: 24194912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxo3a expression is a prognostic marker in breast cancer.
    Jiang Y; Zou L; Lu WQ; Zhang Y; Shen AG
    PLoS One; 2013; 8(8):e70746. PubMed ID: 23967095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.
    Fu G; Peng C
    Oncogene; 2011 Sep; 30(37):3953-66. PubMed ID: 21532621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological significance of forkhead class box O 3a expression in glioma: mediation of glioma malignancy by transcriptional regulation of p27kip1.
    Shi J; Zhang L; Shen A; Zhang J; Wang Y; Zhao Y; Zou L; Ke Q; He F; Wang P; Cheng C; Shi G
    J Neurooncol; 2010 May; 98(1):57-69. PubMed ID: 19911116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer.
    Rehman A; Kim Y; Kim H; Sim J; Ahn H; Chung MS; Shin SJ; Jang K
    J Clin Pathol; 2018 Sep; 71(9):806-813. PubMed ID: 29588373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4'-di-n-octyl genistein.
    Ning Y; Luo C; Ren K; Quan M; Cao J
    Mol Med Rep; 2014 May; 9(5):1982-8. PubMed ID: 24604613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
    Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
    PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer.
    Gao J; Yang X; Yin P; Hu W; Liao H; Miao Z; Pan C; Li N
    Int J Oncol; 2012 Apr; 40(4):1203-9. PubMed ID: 22159921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of galectin-7 in epithelial ovarian cancer.
    Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer.
    Habashy HO; Rakha EA; Aleskandarany M; Ahmed MA; Green AR; Ellis IO; Powe DG
    Breast Cancer Res Treat; 2011 Aug; 129(1):11-21. PubMed ID: 21336599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
    Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
    Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.